Blackstone, Carlyle and KKR Offer $11.1B For Life Tech.

Apr 12 2013 | 10:13am ET

Three private equity firms have bid $11.1 billion for genetic testing equipment maker Life Technologies, expected to be among the biggest buyouts of the year.

The Blackstone Group, the Carlyle Group and Kohlberg Kravis Roberts, along with Singapore state investment company Temasek Holdings, offered $65 per share for the company. But that opening bid is thought to fall short of the between $65 and $75 per share offered by Thermo Fisher Scientific.

Life Technologies is reviewing the bids and is expected to open negotiations with both bidding groups. A deal could be completed within a few days, The Wall Street Journal reports.


In Depth

An Interview With Harvest Volatility Management's Rick Selvala

Mar 23 2017 | 5:39pm ET

Several years of extremely low interest rates have pushed some investors into equities...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

SEI: Private Debt Coming Into Its Own

Mar 8 2017 | 9:24pm ET

The explosive growth of private debt over the past few years has caused the lines...

 

From the current issue of